KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

American Well (AMWL) Research & Development (2019 - 2025)

American Well has reported Research & Development over the past 7 years, most recently at $13.9 million for Q4 2025.

  • Quarterly results put Research & Development at $13.9 million for Q4 2025, down 25.78% from a year ago — trailing twelve months through Dec 2025 was $72.9 million (down 15.34% YoY), and the annual figure for FY2025 was $72.9 million, down 15.34%.
  • Research & Development for Q4 2025 was $13.9 million at American Well, down from $18.6 million in the prior quarter.
  • Over the last five years, Research & Development for AMWL hit a ceiling of $37.5 million in Q1 2022 and a floor of $13.9 million in Q4 2025.
  • Median Research & Development over the past 5 years was $25.9 million (2023), compared with a mean of $25.5 million.
  • Biggest five-year swings in Research & Development: skyrocketed 65.64% in 2022 and later tumbled 30.84% in 2023.
  • American Well's Research & Development stood at $33.8 million in 2021, then fell by 18.04% to $27.7 million in 2022, then fell by 4.83% to $26.3 million in 2023, then decreased by 28.71% to $18.8 million in 2024, then dropped by 25.78% to $13.9 million in 2025.
  • The last three reported values for Research & Development were $13.9 million (Q4 2025), $18.6 million (Q3 2025), and $18.2 million (Q2 2025) per Business Quant data.